Citation:Nietert PJ, Silverstein MD, Mokhashi MS, Kim CY, Glenn TF, Marsi VA, et al 2003

From Cancer Guidelines Wiki

Citation


Nietert PJ, Silverstein MD, Mokhashi MS, Kim CY, Glenn TF, Marsi VA, et al. Cost-effectiveness of screening a population with chronic gastroesophageal reflux. Gastrointest Endosc 2003 Mar;57(3):311-8 Available from: http://www.ncbi.nlm.nih.gov/pubmed/12612508.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Is surveillance cost-effective for follow-up of patients with BO?Dr Louisa Gordoncompleted
For which populations is screening for BO cost-effective?Professor Jon Emery MA, MBBCh, FRACGP, MRCGP, DPhilcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Is surveillance cost-effective for follow-up of patients with BO?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Is surveillance cost-effective for follow-up of patients with BO?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:For which populations is screening for BO cost-effective?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For which populations is screening for BO cost-effective?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. For which populations is screening for BO cost-effective?